Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations-Reference-Cited by-同舟云学术

Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations

Published:2019-01-02 Issue:4 Volume:47 Page:521-536
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clin. Experiment. Ophthalmol

Author:

Ramlogan‐Steel Charmaine A.¹²³,Murali Aparna¹²^ORCID,Andrzejewski Slawomir¹²,Dhungel Bijay²,Steel Jason C.³,Layton Christopher J.¹²^ORCID

Affiliation:

1. LVF Ophthalmology Research Centre, Translational Research Institute Brisbane Australia

2. Greenslopes Clinical School, Faculty of MedicineUniversity of Queensland, Greenslopes Hospital Brisbane Australia

3. Medical and Applied ScienceCentral Queensland University, School of Health Rockhampton Australia

Funder

Gallipoli Medical Research Foundation

Publisher

Wiley

Subject

Ophthalmology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ceo.13416

Reference157 articles.

1. Ocular immune privilege;Zhou R;F1000 Biol Rep,2010

2. The Blood-Retinal Barrier: Structure and Functional Significance

3. Advances in Gene Therapy for Diseases of the Eye

4. Data services and software for identifying genes and mutations causing retinal degeneration;Daiger SP;Invest. Ophthalmol. Vis. Sci.,1998

5. Gene therapy for visual loss: Opportunities and concerns

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2;Gene Therapy;2024-08-12

2. Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency;Molecular Therapy - Methods & Clinical Development;2024-03

3. rAAV-compatible human mini promoters enhance transgene expression in rat retinal ganglion cells;Experimental Eye Research;2024-02

4. Innovative Genoceuticals in Human Gene Therapy Solutions: Challenges and Safe Clinical Trials of Orphan Gene Therapy Products;Current Gene Therapy;2024-02

5. Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks;Heliyon;2024-01